Rating Information (Target Price Changes—Part 2): IBIDEN, Towa Pharmaceutical, etc. (Wealth Advisor)

Morgan Stanley MUFG Securities has reclassified the ratings for stocks including IBIDEN and TOWA PHARMACEUTICAL as the second installment of rating information reviewing stocks’ target prices. Ratings have been changed under a three-tier system.

Read in fullFrom the source, not the headline

sources corroborateOutlets reporting the same event

companies linkedAcross 0 themes, second pass

The story

Morgan Stanley MUFG Securities has reviewed the target prices of stocks as part of its rating information. The stocks covered include IBIDEN and TOWA PHARMACEUTICAL, among others, and their ratings may have been reclassified from their previous levels.

The information is presented under a three-tier framework: Overweight, Equal-weight and Underweight. The specific new target prices and the timing of the updates are not stated in the article.

At a glance

Target companyStocks including IBIDEN and TOWA PHARMACEUTICAL

CategoryA three-tier system of Overweight, Equal-weight and Underweight

Issuing entityMorgan Stanley MUFG Securities Co., Ltd.

DetailsRating information involving changes to target prices

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

google.comNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.